Brief: Jhbp Cy Says NMPA Approves Investigational NDA For Two Gb491 (Lerociclib) Bridging Studies
08/03/2021 01:18
March 8 (Reuters) - JHBP CY Holdings Ltd 6998.HK :
* JHBP CY HOLDINGS LTD - NMPA ADMINISTRATION APPROVES
INVESTIGATIONAL NEW DRUG APPLICATION FOR TWO GB491 (LEROCICLIB)
BRIDGING STUDIES
Source text for Eikon: urn:newsml:reuters.com:*:nHKS8PWbSp
Further company coverage: 6998.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman